Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Related Citations for PubMed (Select 24581826)

1.

A preliminary report of increased plasma levels of IL-33 in bipolar disorder: further evidence of pro-inflammatory status.

Barbosa IG, Morato IB, de Miranda AS, Bauer ME, Soares JC, Teixeira AL.

J Affect Disord. 2014 Mar;157:41-4. doi: 10.1016/j.jad.2013.12.042. Epub 2014 Jan 11.

PMID:
24581826
2.

Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder.

Barbosa IG, Huguet RB, Mendonça VA, Sousa LP, Neves FS, Bauer ME, Teixeira AL.

Eur Arch Psychiatry Clin Neurosci. 2011 Mar;261(2):139-43. doi: 10.1007/s00406-010-0116-z. Epub 2010 May 6.

PMID:
20446090
3.

Reduced levels of interleukin 33 and increased levels of soluble ST2 in subjects with amyotrophic lateral sclerosis.

Lin CY, Pfluger CM, Henderson RD, McCombe PA.

J Neuroimmunol. 2012 Aug 15;249(1-2):93-5. doi: 10.1016/j.jneuroim.2012.05.001. Epub 2012 May 24.

PMID:
22633272
4.

Serum level of interleukin-33 and soluble ST2 and their association with disease activity in patients with Behcet's disease.

Kim DJ, Baek SY, Park MK, Park KS, Lee JH, Park SH, Kim HY, Kwok SK.

J Korean Med Sci. 2013 Aug;28(8):1145-53. doi: 10.3346/jkms.2013.28.8.1145. Epub 2013 Jul 31.

5.

Decreased plasma neurotrophin-4/5 levels in bipolar disorder patients in mania.

Barbosa IG, Morato IB, Huguet RB, Rocha FL, Machado-Vieira R, Teixeira AL.

Rev Bras Psiquiatr. 2014 Oct-Dec;36(4):340-3. doi: 10.1590/1516-4446-2014-1380. Epub 2014 Jul 29.

6.

Circulating levels of GDNF in bipolar disorder.

Barbosa IG, Huguet RB, Sousa LP, Abreu MN, Rocha NP, Bauer ME, Carvalho LA, Teixeira AL.

Neurosci Lett. 2011 Sep 15;502(2):103-6. doi: 10.1016/j.neulet.2011.07.031. Epub 2011 Jul 28.

7.

Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers.

Barbosa IG, Rocha NP, Huguet RB, Ferreira RA, Salgado JV, Carvalho LA, Pariante CM, Teixeira AL.

J Affect Disord. 2012 Mar;137(1-3):151-5. doi: 10.1016/j.jad.2011.12.034. Epub 2012 Jan 16.

PMID:
22252095
8.

Plasma concentrations of soluble cytokine receptors in euthymic bipolar patients with and without subsyndromal symptoms.

Cetin T, Guloksuz S, Cetin EA, Gazioglu SB, Deniz G, Oral ET, van Os J.

BMC Psychiatry. 2012 Sep 26;12:158. doi: 10.1186/1471-244X-12-158.

9.

Increased plasma levels of brain-derived neurotrophic factor in patients with long-term bipolar disorder.

Barbosa IG, Huguet RB, Mendonça VA, Neves FS, Reis HJ, Bauer ME, Janka Z, Palotás A, Teixeira AL.

Neurosci Lett. 2010 May 14;475(2):95-8. doi: 10.1016/j.neulet.2010.03.055. Epub 2010 Mar 27.

PMID:
20350583
10.

Increased BDNF levels in long-term bipolar disorder patients.

Barbosa IG, Rocha NP, Miranda AS, Huguet RB, Bauer ME, Reis HJ, Teixeira AL.

Rev Bras Psiquiatr. 2013 Mar;35(1):67-9.

11.

The levels of soluble ST2 in sera and bullous fluid from patients with bullous pemphigoid.

Wakatabi K, Komine M, Meephansan J, Matsuyama Y, Tsuda H, Tominaga S, Ohtsuki M.

Eur J Dermatol. 2012 May-Jun;22(3):333-6. doi: 10.1684/ejd.2012.1706.

PMID:
22494834
12.

Soluble ST2 levels are associated with bleeding in patients with severe Leptospirosis.

Wagenaar JF, Gasem MH, Goris MG, Leeflang M, Hartskeerl RA, van der Poll T, van 't Veer C, van Gorp EC.

PLoS Negl Trop Dis. 2009 Jun 2;3(6):e453. doi: 10.1371/journal.pntd.0000453.

13.

Chemokines in bipolar disorder: trait or state?

Barbosa IG, Rocha NP, Bauer ME, de Miranda AS, Huguet RB, Reis HJ, Zunszain PA, Horowitz MA, Pariante CM, Teixeira AL.

Eur Arch Psychiatry Clin Neurosci. 2013 Mar;263(2):159-65. doi: 10.1007/s00406-012-0327-6. Epub 2012 May 15.

PMID:
22584806
14.

Plasma levels of alarmin IL-33 are unchanged in autism spectrum disorder: a preliminary study.

Barbosa IG, Rodrigues DH, Rocha NP, Sousa LF, Vieira EL, Simões-E-Silva AC, Kummer A, Teixeira AL.

J Neuroimmunol. 2015 Jan 15;278:69-72. doi: 10.1016/j.jneuroim.2014.11.021. Epub 2014 Nov 26.

PMID:
25595254
15.

Temporal changes of soluble ST2 after cardiovascular interventions.

Willems S, Sels JW, Flier S, Versteeg D, Buhre WF, de Kleijn DP, Hoefer IE, Pasterkamp G.

Eur J Clin Invest. 2013 Feb;43(2):113-20. doi: 10.1111/eci.12022. Epub 2012 Dec 6.

PMID:
23215810
16.

The relationship between interleukin-1 receptor antagonist and cognitive function in older adults with bipolar disorder.

Lotrich FE, Butters MA, Aizenstein H, Marron MM, Reynolds CF 3rd, Gildengers AG.

Int J Geriatr Psychiatry. 2014 Jun;29(6):635-44. doi: 10.1002/gps.4048. Epub 2013 Nov 25.

PMID:
24273017
17.

Immune variations in bipolar disorder: phasic differences.

Ortiz-Domínguez A, Hernández ME, Berlanga C, Gutiérrez-Mora D, Moreno J, Heinze G, Pavón L.

Bipolar Disord. 2007 Sep;9(6):596-602.

PMID:
17845274
18.

Interleukin-1β is associated with depressive episode in major depression but not in bipolar disorder.

Mota R, Gazal M, Acosta BA, de Leon PB, Jansen K, Pinheiro RT, Souza LD, Silva RA, Oses JP, Quevedo L, Lara DR, Ghisleni G, Kaster MP.

J Psychiatr Res. 2013 Dec;47(12):2011-4. doi: 10.1016/j.jpsychires.2013.08.020. Epub 2013 Sep 9.

PMID:
24074516
19.

Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor.

Hope S, Melle I, Aukrust P, Steen NE, Birkenaes AB, Lorentzen S, Agartz I, Ueland T, Andreassen OA.

Bipolar Disord. 2009 Nov;11(7):726-34. doi: 10.1111/j.1399-5618.2009.00757.x.

PMID:
19839997
20.

Elevated serum level of IL-33 and sST2 in patients with ankylosing spondylitis: associated with disease activity and vascular endothelial growth factor.

Li XL, Lin TT, Qi CY, Yuan L, Xia LP, Shen H, Lu J.

J Investig Med. 2013 Jun;61(5):848-51. doi: 10.231/JIM.0b013e31828deed2.

PMID:
23552178
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk